I'm LongbridgeAI, I can summarize articles.During Thursday's intraday session, several healthcare stocks experienced significant volatility. Apimeds Pharmaceuticals surged 162.4% to $6.01, while Surrozen rose 96.16% to $31.7. Other gainers included Greenland Mines, Profusa, GlucoTrack, and Q/C Technologies. Conversely, Artelo Biosciences fell 33.7%, with declines also noted for Bristol-Myers Squibb Celegne Contingent Value Rights, Silexion Therapeutics, Vistagen Therapeutics, Tvardi Therapeutics, and Healthcare Triangle.
Gainers
- Apimeds Pharmaceuticals (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million.
- Surrozen (NASDAQ:SRZN) stock increased by 96.16% to $31.7. The company's market cap stands at $189.9 million.
- Greenland Mines (NASDAQ:GRML) shares rose 36.55% to $15.28. The market value of their outstanding shares is at $35.5 million.
- Profusa (NASDAQ:PFSA) shares increased by 34.63% to $2.76. The company's market cap stands at $1.2 million.
- GlucoTrack (NASDAQ:GCTK) stock increased by 27.09% to $2.58. The market value of their outstanding shares is at $1.6 million.
- Q/C Technologies (NASDAQ:QCLS) stock moved upwards by 26.22% to $1.11. The market value of their outstanding shares is at $7.2 million.
Losers
- Artelo Biosciences (NASDAQ:ARTL) stock fell 33.7% to $4.84 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares declined by 19.86% to $0.1.
- Silexion Therapeutics (NASDAQ:SLXN) shares fell 19.73% to $0.25. The market value of their outstanding shares is at $1.7 million.
- Vistagen Therapeutics (NASDAQ:VTGN) shares declined by 19.58% to $0.3. The company's market cap stands at $16.3 million.
- Tvardi Therapeutics (NASDAQ:TVRD) stock declined by 18.57% to $1.07. The market value of their outstanding shares is at $17.6 million.
- Healthcare Triangle (NASDAQ:HCTI) stock fell 18.32% to $0.74. The market value of their outstanding shares is at $1.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.